$22.58+0.02 (+0.09%)
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally.
PROCEPT BioRobotics Corporation in the Healthcare sector is trading at $22.58 with a market capitalization of $1.5B. Wall Street consensus targets $30.20 (10 analysts), implying a +33.7% move over the next 12 months. The stock is currently near its 52-week low of $19.35, remaining 23.4% below its 200-day moving average. On fundamentals, Piotroski 3/9 flags weak fundamentals, Altman Z in the safe zone. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 75/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $83.13M↑ | $76.38M↓ | $83.33M↑ | $79.18M↑ | $69.16M |
| Gross Profit | $53.95M↑ | $46.31M↓ | $54.01M↑ | $51.75M↑ | $44.16M |
| Operating Income | -$32.61M↓ | -$31.04M↓ | -$23.19M↓ | -$22.19M↑ | -$27.44M |
| Net Income | -$31.64M↓ | -$29.84M↓ | -$21.41M↓ | -$19.58M↑ | -$24.74M |
PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology in the United States and internationally. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic syste...
PROCEPT BioRobotics Corp. (NASDAQ:PRCT) is one of the 10 best robotics and automation stocks to invest in. On May 28, PROCEPT BioRobotics Corp. (NASDAQ:PRCT) disclosed two significant accomplishments in its WATER IV prostate cancer clinical program. Firstly, the company received FDA approval for an Investigational Device Exemption for the second randomized study to evaluate Aquablation […]
BlackBerry, Take-Two initiations among today's top calls on Wall Street
Is PRCT a good stock to buy? We came across a bullish thesis on PROCEPT BioRobotics Corporation on r/ValueInvesting by mrmrmrj. In this article, we will summarize the bulls’ thesis on PRCT. PROCEPT BioRobotics Corporation’s share was trading at $20.91 as of June 17th. Procept BioRobotics (PRCT) is a high-growth surgical robotics company with rapid revenue scaling […]
SpaceX initiated, Intel upgraded: Wall Street's top analyst calls
Pre-Market Stock Futures: Futures are trading higher after a dreadful day on Wall Street, when all the major indices traded lower, and we saw the same pattern that has developed over the last week. The “Buy the Dip” traders come in, briefly get an uptick, and a move higher, and the sellers swarm in to ... Here Are Thursday’s Best Wall Street Analyst Research Calls: Callaway Golf, Chewy, CME Group, Danaher, General Dynamics, Intel, SpaceX, Rocket Lab, Toast, and More